NLS Business

Just ten years ago it was hard to predict the progress that has been made within the field of cancer therapy. A cancer vaccine, including a universal cancer vaccine, as the ultimate goal is for many the holy grail, and several Norwegian companies are paving the way. Cancer accounted for nearly ten million deaths in […]

The United Kingdom’s decision to leave the European Union sent shockwaves across industries, including the life sciences sector. Many companies are grappling with uncertainty and are still struggling to understand the potential implications of Brexit on their operations. Despite this, some opportunities may arise, particularly for the Nordic region, which has close links with the […]

After many years of technical challenges and disappointing results, gene therapy is starting to gain real ground and holds promise within several diseases, ranging from blindness to cancer.

The global pharma company has announced an investment in its global AZ Forest programme, raising its commitment to plant 200 million trees by 2030 and ensure their long-term survival. This includes new or expanded projects in Brazil, India, Vietnam, Ghana and Rwanda that will contribute to the company’s climate action, restore nature, promote biodiversity and […]

The US District Court for the District of New Jersey ruled in favor of Orexo in its patent litigation against Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global, Inc., and Sun Pharmaceutical Industries, Inc. (collectively “Sun”) regarding ZUBSOLV (buprenorphine and naloxone) sublingual tablets (CIII) in the US. The district court found that […]

The conference “Life Sciences – the Era of Personalized Medicine” on June 26-27 at Karolinska Institutet in Solna finalized the Swedish EU presidency. Stockholm Science City was honored to guide tours in Hagastaden, a unique ecosystem for life science researchers and businesses. “The guided tours were very appreciated both by our Swedish and international guests. […]